1. 1Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute,
2. 2Department of Medical Oncology, Netherlands Cancer Institute – Antoni van Leeuwenhoek, Amsterdam, and
3. 3Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands;
4. 4Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom;
5. 5Department of Hematology, and
6. 6Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands; and
7. 7Division of Clinical Studies, Institute of Cancer Research, and the Royal Marsden NHS Foundation Trust, London, United Kingdom.